Basilea Pharmaceutica AG (BSLN) — Tangible Net Worth Ratio
Basilea Pharmaceutica AG (BSLN) has a Tangible Net Worth Ratio of 99.7% as of December 2025. This metric is calculated by deducting intangible assets (CHF371.00K) from net assets (CHF127.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is Basilea Pharmaceutica AG's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Basilea Pharmaceutica AG Tangible Net Worth Ratio (2002–2025)
This chart shows how Basilea Pharmaceutica AG's Tangible Net Worth Ratio has changed across 16 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting net assets of CHF127.94 Million with intangible assets of CHF371.00K CHF. Also explore Basilea Pharmaceutica AG annual equity growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Basilea Pharmaceutica AG (2002–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Basilea Pharmaceutica AG from 2002 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Basilea Pharmaceutica AG (BSLN) total market value.
| Year | Tangible NW Ratio | Net Assets (CHF) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | CHF127.94 Million | CHF371.00K | CHF282.00 Million | ▲ +0.2 pp |
| 2024 | 99.5% | CHF81.00 Million | CHF374.00K | CHF257.76 Million | ▲ +1.9 pp |
| 2015 | 97.7% | CHF14.86 Million | CHF346.00K | CHF398.74 Million | ▼ -1.9 pp |
| 2014 | 99.6% | CHF57.93 Million | CHF224.00K | CHF257.38 Million | ▲ +0.2 pp |
| 2013 | 99.4% | CHF70.87 Million | CHF432.15K | CHF299.76 Million | ▼ 0.0 pp |
| 2012 | 99.4% | CHF105.50 Million | CHF600.03K | CHF375.34 Million | ▲ +0.2 pp |
| 2011 | 99.2% | CHF153.27 Million | CHF1.16 Million | CHF237.09 Million | ▼ -0.3 pp |
| 2010 | 99.5% | CHF210.24 Million | CHF997.43K | CHF316.54 Million | ▲ +1.6 pp |
| 2009 | 97.9% | CHF97.73 Million | CHF2.05 Million | CHF206.61 Million | ▼ -0.7 pp |
| 2008 | 98.6% | CHF199.74 Million | CHF2.77 Million | CHF328.13 Million | ▼ -0.6 pp |
| 2007 | 99.2% | CHF335.10 Million | CHF2.56 Million | CHF461.45 Million | ▼ -0.6 pp |
| 2006 | 99.8% | CHF112.31 Million | CHF172.42K | CHF203.09 Million | ▼ -0.2 pp |
| 2005 | 100.0% | CHF167.87 Million | CHF0.00 | CHF255.56 Million | ▲ +0.0 pp |
| 2004 | 100.0% | CHF209.60 Million | CHF0.00 | CHF230.78 Million | ▲ +0.0 pp |
| 2003 | 100.0% | CHF90.29 Million | CHF0.00 | CHF107.02 Million | ▲ +0.0 pp |
| 2002 | 100.0% | CHF125.38 Million | CHF0.00 | CHF150.51 Million | — |